RSS

CYDY CytoDyn Inc

Mod: mightycydy Asst: HHIGambler,CaptnAmerca
Last Post: 5:40 AM
Followers: 436
Posts Today: 2
Views Today: 38336

CYDY Stock Quote & Tools

$0.2270 ▲ +0.0140 (+6.55%) As of Sep 25, 3:59 PM EDT
Last0.2270
$ Chg0.0140
Open0.2150
High0.2300
Beta1.2374
Year High0.397
Market Cap313.70M
P/B Ratio-2.68
EPS-0.03
Avg Vol (30d)1.45M
Volume1.07M
% Chg+6.55%
Prev Close0.2130
Low0.2051
VWAP0.21980
Year Low0.183
Total Shares1.38B
Shares Out1.38B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

CYDY Stock Message Board Discussion

3 Pinned Posts
Leronlimab (Pro 140) Cliff Notes What is it? Leronlimab is a humanized monoclo (43) by trding
Leronlimab Regulator List (a work in progress) = upregulation = downregulation a-SMA (21) by ohm20
EIND: Information to Submit to Doctors Leronlimab a humanized monoclonal antibody binds CCR5, (38) by ohm20
  1. mountaineer

    Why can i not see this on any of Dr. Drew's websites about this interview. Is it like when i tell

  2. Wealthnotriches

    Kudos to you for this well-researched reply of substance. I am more encouraged than ever with

  3. CDiddy

    One of the common theories is that the Powers that be (FDA and others) are intent on delaying us.

    (2)
  4. mikael

    Drdrew.tv @YoDoctorYo @brucep13 discussing rantes #leronlimab #Aviptadil at 12pm pst/3pm est

  5. Zuess421

    is the 800 shareholders counted by time invested or by amount owned could be the cause of

  6. CDiddy

    For sure. Im guessing, as someone else pointed out, that many investors are buying through

  7. HCIT

    CDiddy, I heard that too from NP, he said recently that they're are now 43K shareholders invested

  8. HCIT

    Hey KolbeB, glad you saw the light over on the OTHER board. You'll know me by ahab333 over there.

  9. JLang

    There are more than one kind of short...

    (1)
  10. bwolfy2002

    Nice! Looks like 525 and 700 mg arms, 90 pts. This is very exciting. 13 weeks of weekly injections,

  11. crazyjogger925

    actually quite a few posters here hold big shares.

    (1)
  12. crazyjogger925

    one of the earlier filings showed us with a 800 plus shareholder count.my fear too some bp will

  13. Zuess421

    Anyone remember if our Nash scientific advisor is from florida?

  14. CDiddy

    I dont believe the 910 shareholders... given it was 43000 not too long ago. but, I think that

  15. CTMedic

    TD, E*Trade,Schwab, etc are account holders of record for all of us small holders. Thus only 910

    (1)
  16. JLang

    What we "got" from the UK? Sure as h--- seems like it to me. Months of back and forth, probably got

    (1)
  17. CTMedic

    All the data goes to the FDA. We collectively cannot even understand topline results, statistical

    (4)
  18. crazyjogger925

    recently released 10k showed only 910 shareholders here and we know few longs selling so where

    (1)
  19. ssb

    hopefully NO PROACTIVE VIDEO. good news for today is that we have DR BP on DR DREW at 3p

  20. Latane

    Thanks TSN - will try to bring value to this board..

  21. reallypeople?

    Todays news our big surprise fromNP ??

  22. ssb

    i agree. it is definitely more positive than the other PR's they have released. the SP seems to

    (2)
  23. CDiddy

    Welcome Latane. Always enjoy your posts.

  24. DaveV-1

    Info & Enrollment in Clinical Trials

    (1)
  25. CDiddy

    Well, for a couple of reasons. First they are not foiling our uplisting plans. And secondly,

    (1)
  26. crazyjogger925

    went through hell finding who to reply to pluto i, checked out awhile. but true so much deception

  27. invisioner

    Does anyone know who I would contact about the cancer basket trial? I wish to find out more for a

  28. jerseylong

    Would it be reasonable to figure that we could use sites in UK for future trials also (NASH,

  29. KolbeB

    This "bashers handbook" is very helpful! While we don't need to respond directly, I think there

  30. crazyjogger925

    plus half of ihub cydy posters may end up here?

  31. tsn

    Welcome Latane. I like your posts on ihub.

  32. Riztheinvestor

    This doesnt change EAU correct ? Lets just say we get EAU, we still enroll CD12 with a phase

  33. nmbr1stckpckr

    EIND is for use with an 'experimental' drug when there are no other options and death is certain.

    (1)
  34. docj

    That is outstanding! Huge market and unmet need. Get this study rolling.

    (1)
  35. Acancel802

    I really think UK and subsequent FDA changing from conference to WRO was a game changer. It was for

    (1)
  36. Latane

    Hello All, Thank you for letting me join your board. Gave up on IHUB due to trolling by

    (7)
  37. nothingspecial

    Tend to agree with much of what you say. But I don't mind saying that I am part of the rest ( a

    (2)
  38. mikael

    @drdrew @YoDoctorYo @brucep13 TODAY at 12pm pst 3pm est. a discussion on treatments for #COVID19.

    (1)
  39. JLang

    I know what RSI is: it's been "low" for a couple of weeks now, since $5... why stop here? If LLmab

    (1)
  40. enemyofpluto

    Wow, the success in the SP today is remarkable! A batch of good news followed by an amateur hit

    (5)
  41. CDiddy

    Welcome PennySlayer

  42. PennySlayer

    New long here. Been window shopping all the boards. I love all your devotion to this product and

  43. CDiddy

    IMO its because the RSI is so low. Shorts want to hit when the share price is over inflated.

    (2)
  44. onestepahead

    Inclusion on CD-12 trial just got easier and should speed up Enrollment as well as U.K accepting

    (2)
  45. JLang

    I'd like to know where all the Shorts went... according to most on this board, they just crashed

    (3)
  46. lorbas

    NASH study registered

    (11)
  47. peacekat

    Thanks. I did it a few months back. How many times can you report him?

  48. TechGuru

    BW, Having the U.K. participating in the CD12 trial is a very good development for us:

    (3)
  49. chuckles759

    I think they only get about 10 responses a day. Most people have them on ignore and just filter

  50. enemyofpluto

    They applied for EUA in UK. Would that cover it, or does an e-IND further improve opportunities to

Top 10 Most Recent News Articles

More News Articles

Top 5 Most Recently Viewed Articles

FRP Holdings, Inc. Set to Announce Q3 Earnings Soon

Updated Category News Views 63

FRP Holdings, Inc. Set to Announce Q3 Earnings Soon FRP Holdings, Inc. (NASDAQ: FRPH) is gearing up for an important update regarding their financial performance. The company is set to release its earnings results for the third quarter on an upcoming Wednesday. This announcement is keenly awaited by analysts and investors alike as it reflects the company's current...

Continue Reading
ACECO's Heartwarming Initiative Distributes Backpacks for Students

Updated Category News Views 126

ACECO Partners with United Way for Community Support In a remarkable effort to support local educational needs, ACECO has engaged its Hoist Up! Outreach Committee to collaborate with the United Way for the distribution of 250 backpacks filled with school supplies. This initiative demonstrates a strong commitment to helping students thrive as they return to school....

Continue Reading
Exploring Iovance Biotherapeutics' Recent Legal Challenges

Updated Category News Views 105

An Overview of Iovance Biotherapeutics Legal Issues Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) has found itself in a challenging position following a recent class-action lawsuit. This situation has arisen due to allegations of securities fraud involving the company and its senior executives. The Class Action Lawsuit Explained The lawsuit, filed by a respected securities...

Continue Reading
Ross Gerber Offers Insightful Take on Tesla and Elon Musk

Updated Category News Views 154

Ross Gerber on His Views About Tesla and Elon Musk Ross Gerber openly shares his thoughts on the dynamic leadership of Elon Musk while at the same time being critical of some of the recent directions of Tesla. During a recent episode of the 'Chasing Finance' podcast, Gerber expressed his mixed feelings stating, “I’m not a fan of Elon.” However, he quickly added,...

Continue Reading
KLA Corporation Adjusts Price Target Yet Maintains Strong Outlook

Updated Category News Views 62

Revised Price Target and Market Insights for KLA Corporation KLA Corporation (NASDAQ: KLAC) has recently seen its stock target adjusted by Stifel to $800, down from $875. Despite this revision, the firm has retained a Buy rating for the company, reflecting confidence in its performance. Stifel noted that KLA exceeded expectations in its latest quarterly performance,...

Continue Reading